Showing results (41-50 of 214) with videos related to
Sort By:
Pageof 22
Journal of Neuroimmunology|December 19, 2016
The clinical characteristics of AQP4 antibody positive NMO/SD in a large cohort of Chinese Han patientsJingzi ZhangBao, Lei Zhou, Xiaoyang Li, et al.Journal of Separation Science|February 23, 2023
Ultra-high performance liquid chromatography-quadrupole/time-of-flight mass spectrometry-based lipidomics reveals key lipid molecules as potential therapeutic targets of Polygonum cuspidatum against hyperlipidemia in a hamster modelNa Yang, Wei Hu, Jun He, et al.Combinatorial Chemistry & High Throughput Screening|December 28, 2023
UPLC-Q-TOF-MS/MS Combined with Network Pharmacology, Molecular Docking, and Animal Verification Reveals the Mechanism of Insomnia Treatment by Shen Qi Wu Wei Zi CapsulesFengyun Bai, Jie Wang, Ning Xia, et al.BMC Neurology|February 19, 2026
Siponimod for relapsing-remitting multiple sclerosis: a single-center, real-world cohort study in ChinaHongmei Tan, Lei Zhou, Yue Gao, et al.Muscle & Nerve|December 27, 2019
Low-dose rituximab every 6 months for the treatment of acetylcholine receptor-positive refractory generalized myasthenia gravisJun Lu, Huahua Zhong, Sisi Jing, et al.Drug Design, Development and Therapy|June 26, 2023
Insight into Nephrotoxicity and Processing Mechanism of Arisaema erubescens (Wall.) Schott by Metabolomics and Network AnalysisMin Wang, Na Yang, Xu Wu, et al.Medicine|February 6, 2021
The therapeutic efficacy of Xuanfei Baidu Formula combined with conventional drug in the treatment of coronavirus disease 2019: A protocol for systematic review and meta-analysisFan Li, Yajuan Li, Jingxia Zhang, et al.Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|June 10, 2026
Discovery of self-assembled nanoparticles from Rubia cordifolia L. before and after carbonization and mechanistic study on their targeted therapy for ulcerative colitisKangjie Li, Runxin Ren, Yiqiong Qi, et al.Expert Opinion on Biological Therapy|May 20, 2026
Real-world implications of efgartigimod in managing refractory myasthenia gravisDingxian He, Nayuan Hu, Chong Yan, et al.European Journal of Neurology|March 13, 2026
Who Can Safely Discontinue Treatment in Myasthenia Gravis? Insights From a Long-Term Real-World StudyDingxian He, Chong Yan, Baitong Wang, et al.Pageof 22